News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
9 | Follower
Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors
Sarepta Therapeutics Announces Results from Part 2 of the EMBARK Study Demonstrating Sustained Benefits and Disease Stabilization in Ambulatory Individuals with Duchenne Muscular Dystrophy Following T
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Marqeta, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - MQ
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
ROSEN, LEADING INVESTOR COUNSEL, Encourages Marqeta, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - MQ